An Interview with Antonio Francesco Di Naro for the C Suite Feature of Sanità33, by Ludovico Baldessin From pioneering ...
Biotech: Angelini Ventures Leads €20 Million Financing Round for NeumirnaNeumirna Therapeutics: Pioneering RNA-Based Therapies for Neurological Disorders
Neumirna Therapeutics, a Danish biotechnology company specializing in RNA-based therapies for next-generation treatments...
Advancing Italian Biotech on the Global Stage: Interim Report Insights (download document)
On October 16, 2024, the Ministry of Foreign Affairs and International Cooperation (MAECI), in collaboration with the Mi...
Harnessing Artificial Intelligence to Unlock the Therapeutic Potential of Plant Bioactives
A Revolutionary Approach to Biodiversity Conservation, Medicinal Discovery, and Sustainable Botanical Production “...
Venture Capital in Biotech: Insights from Giovanni Rizzo (Indaco Venture Partners)
In this interview, Giovanni Rizzo, partner at Indaco Venture Partners, shares his insights on the role of venture capita...
BionIT Labs closes a €5.5 million investment round with CDP Venture Capital Sgr, RIF Srl, Sefea Impact Sgr, SIMEST SpA, and Fondazione ENEA Tech e Biomedical
Investment goal: to make the Adam’s Hand bionic prosthesis the premier product in the American prosthetic market and t...